J mater sci

J mater sci мысль считаю

ответ j mater sci

Keeley FX, Tolley DA. A review of our first 100 cases of laparoscopic nephrectomy: defining risk factors for complications. Kim FJ, Pinto P, Su LM, et al. Ipsilateral orchialgia after laparoscopic donor nephrectomy. McAllister M, Bhayani SB, Ong A, et al. Vena caval transection j mater sci retroperitoneoscopic nephrectomy: report of the complication and review of the literature.

McGinnis DE, Strup SE, Gomella LG. Management of hemorrhage during laparoscopy. Meeks JJ, Zhao LC, Navai N, et al. Risk factors and management of urine leaks after partial ссылка на страницу. Montag S, Rais-Bahrami S, Seideman CA, et al.

Delayed haemorrhage after laparoscopic partial nephrectomy: frequency and angiographic findings. Oefelein M, Bayazit Y. Chronic pain syndrome after laparoscopic radical nephrectomy. Rassweiler J, Fornara P, Weber M, et al. Laparoscopic nephrectomy: the experience of the laparoscopy j mater sci group of the German Urologic Association.

Regan JP, J mater sci ES, Flowers JL. Small bowel obstruction after laparoscopic donor nephrectomy. Schwartz MJ, Faiena I, Cinman N, et al. Laparoscopic bowel injury in retroperitoneal surgery: current incidence and outcomes.

Shapiro EY, Hakimi AA, Hyams ES, et al. Renal artery pseudoaneurysm j mater sci laparoscopic partial nephrectomy. Shuford M, McDougall E, Chang S, et al. Complications of j mater sci radical nephrectomy: comparison of open vs. Thomas AA, Aron M, Hernandez AV, et al. Laparoscopic partial nephrectomy in octogenarians. Varkarakis I, Neururer R, Harabayashi T, et al.

Laparoscopic radical nephrectomy in the elderly. Varkarakis IM, Allaf ME, Bhayani SB, et al. Pancreatic injuries during laparoscopic urologic surgery. Wolf JS, Marchovich R, Gill IS, et al. Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery. PENETRANCE OF MINIMALLY INVASIVE RENAL SURGERY AMONG UROLOGISTS Liu JJ, Leppert JT, Maxwell BG, et al.

Permpongkosol J mater sci, Bagga HS, Romero FR, j mater sci al. Trends in the operative management of renal tumors over a 14-year period. Poon SA, Silberstein JL, Chen LY, et al. Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. Richstone L, Kavoussi LR.

Barriers to the diffusion of advanced surgical techniques. Cadeddu, MD Cryoablation Oncologic Outcomes Radiofrequency Ablation Complications Surgical Technique New Ablation Modalities Treatment Success and Follow-Up Protocol after Tumor Ablation Conclusions T he incidence of localized renal cell carcinoma (RCC) is rising as a result of the increasing use of cross-sectional imaging. According to the Surveillance, Epidemiology, and End Results Program (SEER), in North America the age-adjusted incidence rate of kidney cancer was estimated at 15.

The overall result is a paradigm shift in the management of RCC over the last decade, with an increasing focus on minimally invasive treatment and nephron-sparing surgery. Therefore the j mater sci American Urologic Association (AUA) guidelines for the management of clinical stage 1 renal masses recommends nephron-sparing surgery as standard of care, with consideration of ablative therapies as valid alternatives for older patients or those with substantial comorbidities (Novick et al, 2009).

Irrespective of an open or laparoscopic surgical approach, nephron-sparing surgery is underused in the United States owing to the comparative risks j mater sci attendant technical demands associated with the procedure (Abouassaly et al, 2009).

Thus, to increase the number of patients j mater sci nephron-sparing surgery and broaden the minimally invasive treatment options available to j mater sci with small renal tumors, energy-based, in-situ tumor ablation technologies were introduced in the 1990s. Focal j mater sci therapies offer several advantages compared with extirpative surgery.

First, these modalities are less technically demanding than open, laparoscopic, or robotic partial j mater sci, because renorrhaphy and hilar dissection j mater sci not obligatory.

Finally, all of the ablation modalities offer treatment versatility because they can be deployed in open, laparoscopic, or percutaneous procedures.

Given these advantages, well-recognized indications for ablative treatment include patients with small renal tumors who are either poor surgical candidates or at j mater sci for renal insufficiency, including patients with solitary kidneys, bilateral renal tumors, hereditary syndromes such as von Hippel-Landau disease, and renal insufficiency.

However, because of the excellent results with ablation in these selected patients, there is now growing experience with the treatment of the sporadic small renal tumors in healthy patients (Stern et al, 2009). Together with improved treatment j mater sci systems, more robust http://longmaojz.top/neuromuscular-wustl-edu/nashville.php experience, and improved patient selection, renal ablative technologies are now a viable treatment alternative for small renal tumors.

CRYOABLATION Background and Mode of Action Cryoablation (CA), or cryotherapy, refers to the practice of using extreme cold temperatures to treat a wide variety of pathologic conditions. The use of cold therapy in medicine can be traced j mater sci to the early Egyptians, who used cold to treat inflammatory conditions as early as 2500 Recency effect.

Further...

Comments:

28.05.2020 in 15:55 Андроник:
Полностью с Вами согласна, примерно неделю назад написала про этоже в своем блоге!

01.06.2020 in 16:28 lesmopeti:
На Вашем месте я бы поступил иначе.